{"title":"Are Herbal-peptides Effective as Adjunctive Therapy in Coronavirus Disease COVID-19?","authors":"Elahe Aleebrahim-Dehkordi, Faezeh Soveyzi, Shirin Saberianpour, Mahmoud Rafieian-Kopaei","doi":"10.2174/2589977514666220826155013","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Plant antiviral peptides (AVP) are macromolecules that can inhibit the pathogenesis of viruses by affecting their pathogenic mechanism, but most of these peptides can bind to cell membranes, inhibit viral receptors, and prevent viruses. Recently, due to the coronavirus pandemic, the availability of appropriate drugs with low side effects is needed. In this article, the importance of plant peptides in viral inhibition, especially viral inhibition of the coronavirus family, will be discussed.</p><p><strong>Methods: </strong>By searching the databases of PubMed, Scopus, Web of Science, the latest articles on plant peptides effective on the COVID-19 virus were collected and reviewed.</p><p><strong>Results: </strong>Some proteins can act against the COVID-19 virus by blocking sensitive receptors in COVID-19, such as angiotensin-converting enzyme 2 (ACE2). The 23bp sequence of the ACE2 alpha receptor chain can be considered as a target for therapeutic peptides. Protease and RNAP inhibitors and other important receptors that are active against COVID-19 should also be considered.</p><p><strong>Conclusion: </strong>Herbal medicines with AVP, especially those with a long history of antiviral effects, might be a good choice in complement therapy against the COVID-19 virus.</p>","PeriodicalId":37008,"journal":{"name":"Current Drug Research Reviews","volume":"15 1","pages":"29-34"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Drug Research Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/2589977514666220826155013","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Plant antiviral peptides (AVP) are macromolecules that can inhibit the pathogenesis of viruses by affecting their pathogenic mechanism, but most of these peptides can bind to cell membranes, inhibit viral receptors, and prevent viruses. Recently, due to the coronavirus pandemic, the availability of appropriate drugs with low side effects is needed. In this article, the importance of plant peptides in viral inhibition, especially viral inhibition of the coronavirus family, will be discussed.
Methods: By searching the databases of PubMed, Scopus, Web of Science, the latest articles on plant peptides effective on the COVID-19 virus were collected and reviewed.
Results: Some proteins can act against the COVID-19 virus by blocking sensitive receptors in COVID-19, such as angiotensin-converting enzyme 2 (ACE2). The 23bp sequence of the ACE2 alpha receptor chain can be considered as a target for therapeutic peptides. Protease and RNAP inhibitors and other important receptors that are active against COVID-19 should also be considered.
Conclusion: Herbal medicines with AVP, especially those with a long history of antiviral effects, might be a good choice in complement therapy against the COVID-19 virus.
背景:植物抗病毒肽(AVP)是一种通过影响病毒致病机制来抑制病毒发病的大分子,但这些肽大多能与细胞膜结合,抑制病毒受体,起到预防病毒的作用。最近,由于冠状病毒大流行,需要提供副作用低的适当药物。本文将讨论植物多肽在病毒抑制,特别是冠状病毒家族病毒抑制中的重要性。方法:通过检索PubMed、Scopus、Web of Science等数据库,收集最新的抗新冠病毒植物多肽相关文章并进行综述。结果:部分蛋白可通过阻断血管紧张素转换酶2 (ACE2)等COVID-19敏感受体发挥抗病毒作用。ACE2 α受体链的23bp序列可以被认为是治疗肽的靶标。还应考虑蛋白酶和RNAP抑制剂以及其他对COVID-19有活性的重要受体。结论:含AVP的中草药,特别是具有长期抗病毒作用的中草药,可能是抗COVID-19病毒补充治疗的良好选择。